A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of E6007 in Healthy Subjects.

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of E6007 in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Sep 2014

At a glance

  • Drugs E 6007 (Primary)
  • Indications Inflammatory bowel diseases
  • Focus Adverse reactions
  • Sponsors Eisai Inc
  • Most Recent Events

    • 31 Jan 2012 Actual end date (Oct 2011) added as reported by ClinicalTrials.gov.
    • 31 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Oct 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top